miR-2055p is overexpressed in cancer, directly represses HER2, and indirectly represses EGFR through p63 leading to therapy resistance. Integrin αvβ3 drives the KRAS–RaIB–NF-κB pathway leading to enhanced stemness and resistance. The gene discussed is KRAS; the disease is cancer.